Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | JAK1 |
| Upstream (Parents) |
|---|
| (<<) BCL6 → JAK1 |
| (<<) CCNB2 → JAK1 |
| (<<) CHST2 → JAK1 |
| (<<) LAMB2 → JAK1 |
| (<<) MAP3K12 → JAK1 |
| (<<) PIP5K1C → JAK1 |
| (<<) PRKCB → JAK1 |
| (<<) RPS6KA2 → JAK1 |
| (<<) SYNPO → JAK1 |
| (<<) TIMP3 → JAK1 |
| Downstream (Children) |
|---|
| JAK1 → ADCY7 (>>) |
| JAK1 → BMPR2 (>>) |
| JAK1 → CALML5 (>>) |
| JAK1 → CLPP (>>) |
| JAK1 → CRKL (>>) |
| JAK1 → GAL (>>) |
| JAK1 → GSTM3 (>>) |
| JAK1 → LOC441204 (>>) |
| JAK1 → NRIP1 (>>) |
| JAK1 → PCSK1N (>>) |
| JAK1 → STAT5A (>>) |
| JAK1 → THBS1 (>>) |
| JAK1 → TNF (>>) |
